Psychedelic-assisted psychotherapy: hope and dilemma
The Lancet Regional Health – Europe
The Lancet Regional Health - Europe September 1, 2023 DOI: 10.1016/j.lanepe.2023.100727 (opens in new tab)
Study at a glance
AI-extracted from the abstract| Characteristics | Review Peer reviewed |
|---|---|
| Intervention | Psychedelic-assisted psychotherapy |
| Duration | 18-month follow-up |
| Topics | Psychedelic-assisted therapy |
| Keywords | Dilemma Psychotherapist Psychoanalysis Epistemology |
| Citations | 10 |
| Key findings | Psychedelic-assisted psychotherapy requires fewer treatment regimens than current depression therapies and, in an unpublished study, produced sustained remission of depression at 18 months following a single treatment. |
Abstract
Psychedelic-assisted psychotherapy: hope and dilemmaPsychedelic-assisted psychotherapy is an emerging therapeutic approach that combines the use of psychedelics (a subclass of hallucinogenic drugs) and psychotherapy for the treatment of post-traumatic stress disorder (PTSD) and treatment-resistant depression.Compared with current treatments for depression, psychedelic-assisted psychotherapy has a more direct impact on brain activity, which can result in profound insights and promote introspection, emotional release, and cognitive shifts.Most importantly, it requires fewer treatment regimens, often just one, and in a yet-to-bepublished study, the therapeutic benefits have been shown to result in sustained remission of depression at 18 months following a single treatment.
Comparable studies
Other narrative reviews on psychedelic-assisted therapy, most cited first.
Citations in the library
Cited by 11
- Safety and efficacy of methylenedioxymethamphetamine (MDMA)-assisted psychotherapy in post-traumatic stress disorder: An overview of systematic reviews and meta-analyses. Australian & New Zealand Journal of Psychiatry April 1, 2025
- From Efficacy to Effectiveness: Evaluating Psychedelic Randomized Controlled Trials for Trustworthy Evidence‐Based Policy and Practice Pharmacology Research & Perspectives April 1, 2025
- Placebo Effects: Neurological Mechanisms Inducing Physiological, Organic, and Belief Responses-A Prospective Analysis. Healthcare November 20, 2024
- Australian psychologists' attitudes towards psychedelic‐assisted therapy and training following a world‐first drug down‐scheduling Drug and Alcohol Review November 5, 2024
- Psychedelics in developmental stuttering to modulate brain functioning: a new therapeutic perspective? Frontiers in Human Neuroscience June 19, 2024
and 6 more in the library